Globus Medical (GMED) revenue breakdown
By product, Musculoskeletal Solutions is the largest at 95% of fiscal 2025 revenue, growing 21% a year over 8 years.
By region, United States is the largest at 81% of fiscal 2025 revenue; International grew fastest, 28% a year over 9 years.
Revenue by product
Fiscal years, as Globus Medical reports them in its 10-K filings; fiscal 2025 total $2.9B.
| Products | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| Musculoskeletal Solutions | $625M | $666M | $738M | $748M | $877M | $927M | $1.4B | $2.4B | $2.8B | 95% |
| Enabling Technologies | $11M | $47M | $47M | $41M | $81M | $96M | $120M | $154M | $141M | 5% |
Revenue by region
Fiscal years, as Globus Medical reports them in its 10-K filings; fiscal 2025 total $2.9B.
| Regions | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $500M | $530M | $594M | $648M | $664M | $820M | $872M | $1.3B | $2.0B | $2.4B | 81% |
| International | $64M | $106M | $119M | $138M | $125M | $139M | $151M | $289M | $519M | $571M | 19% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for GMED.
Open GMED in InvestinglyQuestions
Where does Globus Medical make its money?
In fiscal 2025, by product: Musculoskeletal Solutions $2.8B, Enabling Technologies $141M.
From Globus Medical's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.